BioSpace News Archive

Pharm Country

Tris Pharma Presents Clinical Data for DYANAVEL® XR (amphetamine) at the 2018 Neuroscience Education Institute (NEI) Congress

The trial of children 6 to 12 years with ADHD demonstrated that DYANAVEL XR was effective in reducing symptoms of ADHD at 4 hours with a clinical onset at 1 hour and a duration of effect up to 13 hours after dosing

November 12, 2018
·
6 min read
Business

Thomas Jefferson University Helps Launch World’s First International Medical Degree

Physicians can earn degrees to practice medicine in the U.S. and the European Union

November 12, 2018
·
3 min read
Drug Development

KalVista Pharmaceuticals Provides Clinical Update on KVD900

Enlarged Phase 2 Study to Begin in 2018 for Potential Acute Treatment of Hereditary Angioedema; Data Expected in Late 2019

November 12, 2018
·
4 min read
Drug Development

Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration

Trial was designed to evaluate the safety of different dosage regimens of Zimura combination therapy in wet AMD

November 12, 2018
·
8 min read
Staples Canada and Ontario Power Generation Win 2018 Workplace Benefits Awards

Morneau Shepell’s clients recognized by Benefits Canada as leaders in employee benefits

November 12, 2018
·
3 min read
Policy

Avandia drug Canada-wide settlement reached

The Avandia drug class action lawsuit has reached a Canada-wide settlement

November 12, 2018
·
1 min read
Business

ISMIE Mutual Announces New Osteopathic Partnerships

Indiana and Pennsylvania osteopathic associations tap ISMIE as endorsed medical liability carrier

November 12, 2018
·
2 min read
Drug Development

Torque Presents Preclinical Data for Deep IL-15 Primed T Cells, Deep IL-12 Primed T Cells, and for the Slipstream™ Process for Manufacturing These First-in-Class, Multi-Target Cellular Immunotherapies

Torque announced today the presentation of new preclinical data for its lead Deep IL-15 Primed T Cell and Deep Il-12 Primed T Cell therapeutics programs.

November 12, 2018
·
6 min read
Business

CPHI to Hold Third Quarter 2018 Earnings Conference Call On Thursday, November 15, 2018 at 8:30 a.m. ET

China Pharma Holdings, Inc. today announced that it plans to hold its third quarter 2018 earnings conference call on Thursday, November 15, 2018 at 8:30 a.m. ET.

November 12, 2018
·
1 min read
Job Trends

Extinktion Removes Unwanted Hair and Tattoos in Grand Forks, North Dakota Featuring the Astanza ReSmooth and Duality Lasers

Extinktion clinic has invested in the Astanza ReSmooth laser to deliver long-lasting, permanent hair reduction and the Astanza Duality to provide complete tattoo removal, selective tattoo removal, and tattoo lightening for cover-ups.

November 12, 2018
·
2 min read